date/time interval
- April 1, 2022 - March 31, 2025
Intravenous DNase I for the treatment of sepsis: A phase 1 safety and feasibility study in ICU patients
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 265200